Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy

Liver Transpl. 2024 Jun 1;30(6):582-594. doi: 10.1097/LVT.0000000000000302. Epub 2023 Nov 29.

Abstract

The number of kidney after liver transplants (KALT) increased after the implementation of the United Network of Organ Sharing (UNOS) safety net policy, but the effects of the policy on KALT outcomes remain unknown. Using the UNOS database, we identified KALT between 60 and 365 days from liver transplant from January 1, 2010, to December 31, 2020. The main outcome was 1- and 3-year patient, liver, and kidney graft survival. Secondary outcomes included 6-month and 1-year acute rejection (AR) of liver and kidney, and 1-year kidney allograft function. Of the 256 KALT, 90 were pre-policy and 166 post-policy. Compared to pre-policy, post-policy 1- and 3-year liver graft survival was higher (54% and 54% vs. 86% and 81%, respectively, p <0.001), while 1- and 3-year kidney graft survival (99% and 75% vs. 92% and 79%, respectively, p =0.19), and 1- and 3-year patient survival (99% and 99% vs. 95% and 89%, respectively, p =0.11) were not significantly different. Subgroup analysis revealed similar trends in patients with and without renal failure at liver transplant. Liver AR at 6 months was lower post-policy (6.3% vs. 18.3%, p =0.006) but was similar (10.5% vs. 13%, p =0.63) at 1 year. Kidney AR was unchanged post-policy at 6 months and 1 year. Creatinine at 1 year did not differ post-policy versus pre-policy (1.4 vs. 1.3 mg/dL, p =0.07) despite a higher proportion of deceased donors, higher Kidney Donor Profile Index, and longer kidney cold ischemia time post-policy ( p <0.05 for all). This 3-year follow-up after the 2017 UNOS policy revision demonstrated that the safety net implementation has resulted in improved liver outcomes for patients who underwent KALT with no increased AR of the liver or the kidney allografts.

MeSH terms

  • Adult
  • Aged
  • Databases, Factual / statistics & numerical data
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / surgery
  • Female
  • Graft Rejection* / epidemiology
  • Graft Rejection* / etiology
  • Graft Rejection* / prevention & control
  • Graft Survival*
  • Health Policy
  • Humans
  • Kidney / surgery
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / standards
  • Kidney Transplantation / statistics & numerical data
  • Liver Transplantation* / adverse effects
  • Liver Transplantation* / standards
  • Liver Transplantation* / statistics & numerical data
  • Male
  • Middle Aged
  • Retrospective Studies
  • Time Factors
  • Tissue and Organ Procurement* / methods
  • Tissue and Organ Procurement* / standards
  • Tissue and Organ Procurement* / statistics & numerical data
  • Treatment Outcome
  • United States / epidemiology